No Longer In Short Supply: US FDA Pulls N95s From Shortage List
The US FDA has removed N95s respirator masks from its medical device shortage list, citing increased domestic production.
You may also be interested in...
The US agency has updated it device shortage list, adding two devices to the list of products in short supply while removing two others.
The US FDA’s Resilient Supply Chain Program (RSCP) will be housed in the agency’s Office of Strategic Partnerships and Technology Innovation and aims to reduce future supply chain shortages by applying lessons learned during the pandemic.
The Centers for Medicare and Medicare Services is considering payment adjustments to hospitals for domestic N95 respirator masks to compensate for the added costs facilities incurred to acquire the face coverings during the pandemic.